Aristippos Gennadios, Group President Pharma & Consumer at Catalent, Inc. (CTLT), sold 403 shares at $106.90 ($43K) on 2022-07-26, disclosed to the SEC on 2022-07-28.
Seasonal sale ($43k) by Group President Pharma & Consumer — this insider has traded CTLT in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CTLT | SELL | 2023-08-25 | $18K | — | Filing → |
| CTLT | SELL | 2023-08-03 | $13K | — | Filing → |
| CTLT | SELL | 2022-08-26 | $339K | — | Filing → |